Stay updated on Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page now displays a recruitment-status note indicating that the study is no longer enrolling participants.
    Difference
    0.2%
    Check dated 2026-06-16T00:23:14.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.4 to v3.5.5, reflecting a minor metadata update rather than substantive changes to study details.
    Difference
    0.0%
    Check dated 2026-06-09T01:31:32.000Z thumbnail image
  4. Check
    21 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    A new page revision tag, v3.5.4, was added and the previous v3.5.3 tag was removed, indicating a minor version update.
    Difference
    0.0%
    Check dated 2026-05-18T13:28:04.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page footer revision was updated from v3.5.2 to v3.5.3, reflecting a site release/update rather than any change to the study record details.
    Difference
    0.0%
    Check dated 2026-04-27T07:43:39.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2; revision v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-20T03:28:33.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T08:57:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page.